The National Cancer Institute is renewing its collaboration with the Huntsman Cancer Institute to continue collecting data on cancer patients treated in Utah.
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these...
SCM Lifescience Co., Ltd. and the University of Utah announced that they have entered into a collaborative research agreement to generate cell sheets and complete a functional evaluation of the...
Jeff Cline, MD, board certified pediatrician and Community Physician Group medical director at Greenwood Health Center, was honored recently as this year's "Preceptor of the Year" by the Utah Area...
On paper, Alan is almost a perfect picture of health. But despite his easy-going nature and the platitudes he sprinkles throughout conversation, Alan is a warrior fighting against the ALS...
The study, co-led by the Moffitt Cancer Centre, found that women who reported taking a low-dose aspirin every day had a 23 per cent lower risk of ovarian cancer compared...
Regular use of aspirin can reduce the risk of developing ovarian cancer and hepatocellular carcinoma, according to two studies published Oct. 4 in JAMA Oncology.
An analysis of data from hundreds of thousands of women in the United States has found that regularly taking low-dose aspirin is linked to a lower risk of developing ovarian...
Two new studies examining different aspirin doses in different cancers add to the mounting evidence for the drug's beneficial role in reducing cancer risk.
Taking low-dose aspirin is a daily routine for many people because it may lower the risk for heart attacks and strokes, and some research has tied it to a lower...
Women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23% lower risk of developing ovarian cancer when compared with women who did not regularly...
The reputation of aspirin has received another boost, with the publication of studies that suggest that it may help reduce the risk of liver and ovarian cancer.
The Vitae Vignettes video series celebrates the people and stories that drive our research. Watch the video to see what inspires biochemist Claudio Villanueva and his search for novel solutions...
With a goal of leveraging the Utah Translational Hypertension Symposium to make an impact, the organizers created a unique, intimate setting where researchers and in-the-trenches clinicians could problem solve with...
